• Clinical Insights: September 21, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Exkivity™ (mobocertinib) Capsules – New Drug Approval – September 15, 2021 – The Food and Drug Administration granted accelerated approval to mobocertinib (Exkivity™, Takeda Pharmaceuticals, Inc.) for adult patients… Read more »

  • Clinical Insights: September 14, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New/Updated Drug Shortage September 10, 2021 Atropine Sulfate Injection (Currently in Shortage) Bacitracin… Read more »

  • Clinical Insights: September 8, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Trudhesa™ (dihydroergotamine mesylate) Nasal Spray – New Drug Approval – September 3, 2021 –  Impel NeuroPharma, Inc., a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from… Read more »

  • Clinical Insights: August 31, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Tibsovo® (ivosidenib) – New Drug Approval – August 25, 2021 – The Food and Drug Administration approved ivosidenib (Tibsovo®, Servier Pharmaceuticals LLC) for adult patients with previously treated,… Read more »

  • Register for 2021 340B Health Webinar on 9/1

    Register now for the upcoming 340B Health webinar, “340B Updates from the Field: Series 4” on September 1. Join Rhodie Smith, L.L.B., J.D., Vice President – Contract Pharmacy Sales, as he reviews detailed tracking of 340B reinvestment, compliance and audit considerations for hospitals when creating a slide (cash program) program for uninsured patients.  Session objectives… Read more »

  • Clinical Insights: August 24, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Comirnaty™ (Pfizer-BioNTech COVID-19 Vaccine) – New Vaccine Approval – August 23, 2021 – The U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been… Read more »

  • Clinical Insights: August 17, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Welireg™ (belzutifan) Tablets – New Drug Approval – August 13, 2021 – The Food and Drug Administration approved belzutifan (Welireg™, Merck), a hypoxia-inducible factor inhibitor for adult patients with… Read more »

  • Let’s Connect at the 2021 CHI & EXPO

    Connect with Rhodie Smith during the National Association of Community Health Centers 2021 Community Health Institute (CHI) & EXPO, August 22-24. With the theme, “America’s Health Centers: Change Leaders in Health Care for the Future,” this hybrid event will provide virtual and in-person attendees the opportunity to connect and share insights. Make sure to visit… Read more »

  • Clinical Insights: August 10, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Nexviazyme® (avalglucosidase alfa-ngpt) Intravenous Infusion – New Orphan Drug Approval – August 6, 2021 – The U.S. Food and Drug Administration approved Genzyme’s Nexviazyme® (avalglucosidase alfa-ngpt) for intravenous… Read more »

  • Celebrate National Health Center Week 2021

    At RxStrategies, we are so grateful for the support and quality care provided by Community Health Centers across the U.S. and are honored to support their efforts. With the continued impact of the COVID-19 pandemic, we recognize the health care professionals on the front-line who are the chemistry for our strong communities. Learn more about… Read more »